View Older Stories View More Recent Stories

Nov 29, 2022 04:27PM Form SC 13D/A scPharmaceuticals Inc. Filed by: ORBIMED ADVISORS LLC
Nov 25, 2022 08:14PM Form 4 Tricida, Inc. For: Nov 22 Filed by: ORBIMED ADVISORS LLC
Nov 25, 2022 04:58PM Form SC 13D/A Tricida, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 17, 2022 10:00AM Scribe Therapeutics to Participate in Four Upcoming Conferences
Nov 14, 2022 04:12PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 10, 2022 04:27PM Form SC 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 10, 2022 08:02AM Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment
Nov 8, 2022 04:04PM ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 7, 2022 04:26PM Form SC 13D/A Keros Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 1, 2022 08:30AM J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies
Oct 19, 2022 10:12AM PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer
Oct 10, 2022 08:00AM Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer
Sep 29, 2022 04:00PM Scribe Therapeutics to Participate in Upcoming Investor Conferences
Sep 28, 2022 04:24PM Form SC 13D Third Harmonic Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 27, 2022 04:29PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Sep 27, 2022 07:00AM Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer
Sep 21, 2022 06:01PM Form 4 Third Harmonic Bio, Inc. For: Sep 19 Filed by: ORBIMED ADVISORS LLC
Sep 20, 2022 01:01PM Regeneron Co-Founder and Former Moderna Chief Medical Officer Among Healthcare Innovators to Speak at Klick Ideas Exchange
Sep 16, 2022 04:24PM Form SC 13D/A Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
Sep 14, 2022 06:11PM Form 3 Third Harmonic Bio, Inc. For: Sep 14 Filed by: ORBIMED ADVISORS LLC
Sep 14, 2022 04:35PM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Sep 14, 2022 04:25PM Form 4 SpringWorks Therapeutics For: Sep 12 Filed by: ORBIMED ADVISORS LLC
Aug 30, 2022 04:38PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Aug 26, 2022 04:14PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 24, 2022 08:00AM Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer
Aug 23, 2022 09:50AM 4 Penny Stocks Insiders Spent Millions To Buy In August 2022
Aug 19, 2022 04:18PM Form SC 13D/A TELA Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 18, 2022 04:39PM Form SC 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 17, 2022 04:32PM Form 4 Xtant Medical Holdings, For: Aug 15 Filed by: ORBIMED ADVISORS LLC
Aug 15, 2022 04:32PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2022 02:30PM Form SC 13D/A Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
Aug 10, 2022 04:23PM Form 4 SpringWorks Therapeutics For: Aug 08 Filed by: ORBIMED ADVISORS LLC
Aug 8, 2022 04:27PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 1, 2022 04:05PM TransMedics Reports Second Quarter 2022 Financial Results
Jul 26, 2022 10:00AM Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires
Jul 15, 2022 10:00AM Scribe Therapeutics to Participate in SVB Securities Biopharma Private Company Connect
Jul 11, 2022 08:14AM Enavate Sciences Appoints Industry Veteran Robert Glassman as Executive Vice President, Search & Evaluation
Jul 5, 2022 04:31PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 28, 2022 04:23PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 23, 2022 09:15AM Radius Health (RDUS) Acquired by Gurnet Point Capital and Patient Square Capital for $10/sh Plus CVR of $1/sh
Jun 23, 2022 09:15AM Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
Jun 23, 2022 09:15AM Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
Jun 22, 2022 06:00AM Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
May 25, 2022 03:00PM Chau Khuong Joins Catalio Capital Management as General Partner
May 16, 2022 04:27PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 5, 2022 05:33PM Form 4 Passage BIO, Inc. For: May 03 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:21PM Form 4/A Passage BIO, Inc. For: Jan 20 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:14PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories